Oncologist and cancer researcher Dr. William Makis uncovers what Big Pharma doesn’t want you to know about ivermectin’s anti-cancer mechanisms.

Ivermectin selectively inhibits the proliferation of tumors at a dose that is not toxic to normal cells and can reverse the MDR (multi-drug resistance) of tumors.

Ivermectin exerts anti-cancer effects through at least 15 different pathways proven in the medical literature, both in vitro and in vivo!

https://tinyurl.com/554yyauj